At Fridays, we make it easy for individuals to gain access to compounded medications that can help them along their weight loss journey
The daily pill, developed by Novo Nordisk, offers a non-injectable alternative to popular GLP-1 shots like Ozempic and Wegovy, lowering a key barrier for patients who are unwilling or unable to use injections
The body fights to return to its previous set point with remarkable persistence
Other GLP-1 medications may have varying durations, but the principle remains the same: the longer the half-life, the longer the hormone stays active in your system
Overweight and obesity management (NG246) full guideline PDF NICE
GLP-1 Microdosing Chart & Schedule According to a 2,700-person real-world study presented at the 2025 European Congress on Obesity, participants achieved an average 16% weight loss over 64 weeks at microdose levels of semaglutide: Microdosing GLP-1 Weight Loss Results Microdose GLP-1 yields 5-10% body weight loss in year one versus 15-20% with full-dose treatment plans
